Aditxt (NASDAQ:ADTX) Major Shareholder Financial Lp Hrt Sells 735,462 Shares

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt sold 735,462 shares of the company’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $0.06, for a total transaction of $44,127.72. Following the sale, the insider directly owned 505,302 shares in the company, valued at approximately $30,318.12. This trade represents a 59.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Thursday, June 4th, Financial Lp Hrt bought 843,622 shares of Aditxt stock. The stock was acquired at an average price of $0.08 per share, with a total value of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The stock was sold at an average price of $7.56, for a total transaction of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total transaction of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt purchased 2,700 shares of Aditxt stock. The shares were acquired at an average price of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total transaction of $3,588.30.

Aditxt Stock Performance

Aditxt stock traded down $0.01 during mid-day trading on Monday, reaching $0.05. The company’s stock had a trading volume of 34,601,770 shares, compared to its average volume of 2,810,720. The firm’s fifty day moving average price is $7.80 and its two-hundred day moving average price is $170.33. Aditxt, Inc. has a 12-month low of $0.05 and a 12-month high of $53,451.08. The company has a market capitalization of $40,718.40, a P/E ratio of 0.00 and a beta of 0.84.

Aditxt (NASDAQ:ADTX) last posted its earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share (EPS) for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Wall Street Analyst Weigh In

Several research analysts have commented on ADTX shares. Wall Street Zen upgraded Aditxt to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aditxt presently has an average rating of “Sell”.

Aditxt Company Profile

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.